Compare HUM & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HUM | A |
|---|---|---|
| Founded | 1961 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.5B | 39.8B |
| IPO Year | 2002 | 1999 |
| Metric | HUM | A |
|---|---|---|
| Price | $169.47 | $110.35 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 20 | 16 |
| Target Price | ★ $241.60 | $161.06 |
| AVG Volume (30 Days) | 1.3M | ★ 2.1M |
| Earning Date | 04-29-2026 | 02-25-2026 |
| Dividend Yield | ★ 2.02% | 0.90% |
| EPS Growth | N/A | ★ 3.16 |
| EPS | ★ 9.84 | 1.07 |
| Revenue | ★ $129,664,000,000.00 | $4,472,000,000.00 |
| Revenue This Year | $25.39 | $8.45 |
| Revenue Next Year | $6.08 | $6.10 |
| P/E Ratio | ★ $17.76 | $106.10 |
| Revenue Growth | ★ 10.11 | 6.43 |
| 52 Week Low | $163.11 | $96.43 |
| 52 Week High | $315.35 | $160.27 |
| Indicator | HUM | A |
|---|---|---|
| Relative Strength Index (RSI) | 39.10 | 32.80 |
| Support Level | $163.36 | N/A |
| Resistance Level | $192.01 | $122.96 |
| Average True Range (ATR) | 5.55 | 2.71 |
| MACD | 1.85 | 0.52 |
| Stochastic Oscillator | 47.47 | 6.35 |
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.